"Appendix C-IV - Experiments Involving 
Bacillus subtilis or Bacillus lichenif ormis 
Host-Vector Systems. 
"Any asporogenic Bacillus subtilis 
or asporogenic Bacillus 
lichenif ormis strain. ..." 
Mr. Brewer seconded the motion. Whereupon, there being no 
further discussion, the motion was put to a vote by Dr. McGarrity 
and passed by a vote of 14 in favor, none opposed, and one 
abstention. 
X. FUTURE MEETING DATES (tab 1325, 1326). 
Dr. McGarrity reminded the committee of the next meeting of the 
Recombinant DNA Advisory Committee which will be October 3, 1988 
in Bethesda, Maryland, and advised members interested that the 
Human Gene Therapy Subcommittee would meet on July 29, 1988 in 
Bethesda, Maryland. 
XI. RETIRING MEMBERS OF RAC. 
Dr. McGarrity presented certificates of appreciation from the 
U.S. Department of Health and Human Services, the Public Health 
Service and the National Institutes of Health to the following 
retiring members of the committee and thanked them for their wise 
counsel and participation over their terms on the committee: Dr. 
Mitchell Cohen, Dr. Irving Johnson, Dr. Edward Korwek, Dr. Ann 
Vidaver, and Dr. David Pramer. 
Having concluded the agenda and there being no further business 
to be discussed, Dr. McGarrity adjourned the committee at 3:31 
p.m., on June 3, 1988. 
Recombinant DNA Research, Volume 13 
[165] 
